Last Saturday, (the next generation sequencing (NGS)) full genome analysis celebrated its 10th anniversary.
Since then NGS technology has been progressively spread in more and more laboratories, giving access to quick-to-perform genetic analysis at lower cost. It has provided researchers the opportunity to make new discoveries.
It reminds us how advances in technologies can contribute to medical progress.
Similarly, technological progress in sequencing activities (such as digital PCR, micro RNA sequencing …) represents essential tools for Biogazelle (our 2015 laureate) whose aim is to deliver new diagnostics and therapeutics for medical progress.